We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Statistics on NHS Stop Smoking Services - England, April 2007 to March 2008, Annual reportOfficial statistics
- Publication Date:
- 21 Aug 2008
- Geographic Coverage:
- Geographical Granularity:
- Strategic Health Authorities, Primary Care Organisations, Government Office Regions
- Date Range:
- 01 Apr 2007 to 31 Mar 2008
This statistical report presents final results from the monitoring of the NHS Stop Smoking Services for the period April 2007 to March 2008.
In 2007/08 new data items have been added to the collection. Information is now available for successful quitters by treatment option and ethnicity. Also, this is the first year that information on the use of varenicline (champix) as a pharmacotherapy has been included.
The report also presents data by Strategic Health Authority and Primary Care Trust. Some information has also been provided in this report in relation to smoking prevalence and attitudes to smoking to help put these results into context.
During the period April 2007 to March 2008:
- 680,289 people set a quit date through the NHS Stop Smoking Services, an increase of 13 per cent since 2006/07
- at the four week follow-up 350,800 people had successfully quit (based on self-report), 52 per cent of those setting a quit date. This compares with 319,720 successful quitters in 2006/07 (an increase of 10 per cent)
- more women than men set a quit date in 2007/08 (373,000 compared with 307,289) and more women than men successfully quit (188,708 compared with 162,092), although the success rate of giving up smoking was slightly higher among men than women (53 per cent and 51 per cent respectively)
- of those setting a quit date, success rates generally increased with age, from 38 per cent of those aged under 18, to 60 per cent of those aged 60 and over
- people from ethnic minority groups accounted for three per cent of those setting a quit date in 2001/02 (7,366), compared to six per cent in 2007/08 (37,734)
- the success rate of giving up smoking was highest among those in the Mixed and White ethnic groups (52 per cent and 51 per cent respectively) and lowest among those in the Black and Black British group (45 per cent)
- of the 18,977 pregnant women who set a quit date, 9,817 successfully quit (52 per cent)
- the majority of those setting a quit date received Nicotine Replacement Therapy (NRT) only (70 per cent). A further 14 per cent received varenicline (Champix) only, three per cent received bupropion (Zyban) only and less than one per cent received both NRT and bupropion. Six per cent of people setting a quit date did not receive any pharmacotherapy and the type of treatment was unknown for a further six per cent
- Varenicline was the most successful pharmacotherapy in helping people quit. Of those who used varenicline 63 per cent successfully quit, compared with 53 per cent who received bupropion only, and 49 per cent who received NRT. Fifty-five per cent of people who did not receive any type of pharmacotherapy successfully quit
- expenditure on NHS Stop Smoking Services was almost £61 million in 2007/08 nearly £10 million higher than in 2006/07 and almost £36 million more than expenditure in 2001/02. The cost per quitter was £173 in 2007/08. This has increased by eight per cent since 2006/07 but is down overall since 2001/02 when the cost per quitter was £206